Award
Delivery Order #SPE2DR26FY9FK
Delivery Order for Novolog Insulin FlexPen under Long-Term Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$2,048.50
Ceiling
$2,048.50
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FY9FK
NAICS
424210
This contract is a delivery order awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company, under an existing long-term pharmaceutical supply indefinite delivery vehicle. The award facilitates the procurement of Novolog 100 unit/mL FlexPen 3mL, an essential insulin product used in diabetes treatment. The contract plays a critical role in maintaining a reliable supply chain for vital medications within healthcare operations, directly supporting patient care and treatment efficacy. The scope of work involves a short-term, precise delivery of the specified insulin product to the designated location in Conshohocken, PA. This delivery order operates under a competitive framework established by the parent long-term contract and ensures timely fulfillment within a concise performance period. The contract's timeline is brief, covering performance over a few days in early 2026.
Description
4570903053!NOVOLOG 100 UNIT/ML FLEXPEN 3ML